Your browser doesn't support javascript.
loading
Efficacy and Safety of High-dose Cholecalciferol in Patients With Inflammatory Bowel Disease Receiving Infliximab.
Gordon, Rebecca J; Wells, Reeder; Johansen, Camille; Liu, Shanshan; Dahlberg, Suzanne E; Snapper, Scott B; Rufo, Paul A.
Afiliación
  • Gordon RJ; Division of Endocrinology.
  • Wells R; Division of Gastroenterology, Hepatology, and Nutrition, Inflammatory Bowel Disease Center.
  • Johansen C; Division of Gastroenterology, Hepatology, and Nutrition, Inflammatory Bowel Disease Center.
  • Liu S; Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Dahlberg SE; Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Snapper SB; Division of Gastroenterology, Hepatology, and Nutrition, Inflammatory Bowel Disease Center.
  • Rufo PA; Division of Gastroenterology, Hepatology, and Nutrition, Inflammatory Bowel Disease Center.
J Pediatr Gastroenterol Nutr ; 74(4): 476-483, 2022 04 01.
Article en En | MEDLINE | ID: mdl-35045559
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Colecalciferol / Infliximab Tipo de estudio: Observational_studies Límite: Adult / Child / Humans Idioma: En Revista: J Pediatr Gastroenterol Nutr Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Colecalciferol / Infliximab Tipo de estudio: Observational_studies Límite: Adult / Child / Humans Idioma: En Revista: J Pediatr Gastroenterol Nutr Año: 2022 Tipo del documento: Article